Precision medicine for gastrointestinal cancers: a conference report

• Authors: Ibrahim Halil Sahin, Emory University
• Journal Title: Future Science OA
• Volume: Volume 6, Number 6
• Publisher: Future Science | 2020-07-01
• Type of Work: Article | Final Publisher PDF
• Publisher DOI: http://doi.org/10.2144/fsoa-2020-0061
• Subjects: Health Sciences, Oncology; Health Sciences, Immunology; Biology, Cell; Health Sciences, Rehabilitation and Therapy
• Keywords: cholangiocarcinoma; colorectal cancer; gastric cancer; gastrointestinal cancers; hepatocellular carcinoma; IDH mutations; immunotherapy; pancreatic cancer; precision medicine

Abstract

As cancer management evolves into precision medicine national/international cancer meetings bring novel therapeutic approaches and potentially practice-changing results of clinical studies are presented. This year, the ASCO GI Symposium 2020 had also several updates from ongoing and finalized clinical trials. Although there were no groundbreaking results that impact the daily practice directly, several highly important data from ongoing studies were shared with the audience. In this report, the highlights of the ASCO GI Symposium 2020 are presented with a future perspective.